Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

NCT00019539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer

Interventions

DRUG: bevacizumab
DRUG: thalidomide

Sponsor

National Cancer Institute (NCI)